Status:
NOT_YET_RECRUITING
TDCS as Augmentation Therapy to Cognitive Training in Mild Dementia
Lead Sponsor:
Hospital Authority, Hong Kong
Collaborating Sponsors:
The University of Hong Kong
Conditions:
Major Neurocognitive Disorder
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
Due to increase in life expectancy, major neurocognitive disorder (MND) becoming increasingly important as reflected in the increasing number in dementia population, as well as in burden to health car...
Detailed Description
Due to increase in life expectancy, major neurocognitive disorder (MND) becoming increasingly important as reflected in the increasing number in dementia population, as well as in burden to health car...
Eligibility Criteria
Inclusion
- 65 years of age or above
- Right-handedness Chinese as defined by Edinburgh handedness inventory
- Cantonese speaking
- Fulfil the criteria of Major neurocognitive disorder, as defined by the 5 th Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM- 5)
- Clinical Dementia Rating Global score = 1
Exclusion
- Active diagnosis of mood disorder or psychosis
- Alcohol or substance dependence
- Initiation or change in dose of cognitive enhancer within 6 months prior to the onset of the study 14
- Poor physical condition and mobility
- Having regular cognitive training (as defined by at least three 1-hour weekly structured and standardized cognitive training in recent 3 months) 15
- Receiving tDCS within 2 months prior to the onset of study 16
- Significant communication or visual impairment
- Having metal implant in area above upper back, or having metal crown or metal brace, or pacemaker
Key Trial Info
Start Date :
September 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2025
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT06559254
Start Date
September 1 2024
End Date
September 30 2025
Last Update
August 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Mary Hospital
Hong Kong, Hong Kong